SG10201911206PA - Placental-derived stem cells to restore the regenerative engine, correct proteomic defects and extend lifespan - Google Patents

Placental-derived stem cells to restore the regenerative engine, correct proteomic defects and extend lifespan

Info

Publication number
SG10201911206PA
SG10201911206PA SG10201911206PA SG10201911206PA SG10201911206PA SG 10201911206P A SG10201911206P A SG 10201911206PA SG 10201911206P A SG10201911206P A SG 10201911206PA SG 10201911206P A SG10201911206P A SG 10201911206PA SG 10201911206P A SG10201911206P A SG 10201911206PA
Authority
SG
Singapore
Prior art keywords
proteomic
placental
restore
defects
correct
Prior art date
Application number
SG10201911206PA
Other languages
English (en)
Inventor
Robert Hariri
Original Assignee
Celularity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celularity Inc filed Critical Celularity Inc
Publication of SG10201911206PA publication Critical patent/SG10201911206PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/54Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073Stem cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
SG10201911206PA 2015-05-28 2016-05-27 Placental-derived stem cells to restore the regenerative engine, correct proteomic defects and extend lifespan SG10201911206PA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562167786P 2015-05-28 2015-05-28

Publications (1)

Publication Number Publication Date
SG10201911206PA true SG10201911206PA (en) 2020-01-30

Family

ID=57393743

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201911206PA SG10201911206PA (en) 2015-05-28 2016-05-27 Placental-derived stem cells to restore the regenerative engine, correct proteomic defects and extend lifespan

Country Status (16)

Country Link
US (1) US20160346333A1 (pt)
EP (1) EP3302065A4 (pt)
JP (3) JP2018520211A (pt)
KR (2) KR20180019613A (pt)
CN (1) CN107846903A (pt)
AU (2) AU2016267672A1 (pt)
BR (1) BR112017025586A2 (pt)
CA (1) CA2987064A1 (pt)
CO (1) CO2017013359A2 (pt)
EA (1) EA201792602A1 (pt)
IL (1) IL255920B2 (pt)
MX (1) MX2017015145A (pt)
NZ (1) NZ737474A (pt)
SG (1) SG10201911206PA (pt)
WO (1) WO2016191724A1 (pt)
ZA (1) ZA201707905B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110809718A (zh) * 2017-06-21 2020-02-18 韩国生命工学研究院 利用血液生物标志物诊断肌肉衰弱相关疾病的方法和试剂盒
WO2019236632A1 (en) * 2018-06-04 2019-12-12 Avon Products. Inc. Protein biomarkers for identifying and treating aging skin and skin conditions
BR112021001190A2 (pt) * 2018-07-22 2021-04-27 Minovia Therapeutics Ltd. terapia de reforço mitocondrial para doenças mitocondriais primárias
KR20200055979A (ko) 2018-11-14 2020-05-22 (주)아모레퍼시픽 피부 노화 모델의 제조방법, 그 방법에 의해 제조된 피부 노화 모델 및 그 피부 노화 모델을 이용한 항노화 물질의 스크리닝 방법
CN109355393A (zh) * 2018-12-12 2019-02-19 武汉凯德维斯生物技术有限公司 宫颈小细胞癌相关的hpv整合基因位点及其应用
US20220160787A1 (en) * 2019-03-15 2022-05-26 Celularity Inc. Placenta derived adherent cells for improved xenoplantation
CN109908323A (zh) * 2019-04-01 2019-06-21 李胜 一种促成人体骨髓干细胞再生和激活休眠干细胞的复方制品制作方法
CN110179827A (zh) * 2019-06-27 2019-08-30 北京三有利和泽生物科技有限公司 牙源性间充质干细胞的应用
TWI761837B (zh) * 2020-05-20 2022-04-21 國立中央大學 通用人類誘導多能性幹細胞及其生成方法
CN112129877B (zh) * 2020-09-24 2021-07-20 南京医科大学 精浆甘露糖-6-磷酸和新蝶呤检测作为特发性男性不育诊断标志物及其应用
WO2023061484A1 (zh) * 2021-10-14 2023-04-20 北京干细胞与再生医学研究院 年轻化非多能性细胞及其制备方法和应用
WO2023090901A1 (ko) * 2021-11-18 2023-05-25 의료법인 성광의료재단 기계 학습을 이용한 세포 노화의 마커를 선별하는 방법, 세포 노화 바이오 마커, 및 이를 이용한 세놀리틱 제제를 스크리닝 하는 방법
WO2024085637A1 (ko) * 2022-10-18 2024-04-25 동국대학교 산학협력단 혈장 유래 단백질을 포함하는 노화 방지용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021767A2 (en) * 1999-09-24 2001-03-29 Morphogen Pharmaceuticals, Inc. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
KR20190104428A (ko) * 2005-12-29 2019-09-09 안트로제네시스 코포레이션 태반 줄기 세포 집단
NZ595854A (en) * 2006-10-23 2013-04-26 Anthrogenesis Corp Methods and compositions for treatment of bone defects with placental cell populations (ELOVL2, ST3GAL6, STGALNAC5, SLC12A8)
CA2677679A1 (en) * 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
MX349225B (es) * 2007-02-12 2017-07-19 Anthrogenesis Corp Uso de celulas madre placentarias para preparar medicamentos utiles en el tratamiento de padecimientos inflamatorios.
US9962409B2 (en) * 2007-10-01 2018-05-08 Vestion, Inc. Therapy using cardiac stem cells and mesenchymal stem cells
CN101748096B (zh) * 2008-12-17 2013-03-13 北京汉氏联合生物技术有限公司 亚全能干细胞、其制备方法及其用途
ES2358146B1 (es) * 2009-10-22 2012-03-23 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud En Sevilla Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis.

Also Published As

Publication number Publication date
JP2023116745A (ja) 2023-08-22
US20160346333A1 (en) 2016-12-01
CN107846903A (zh) 2018-03-27
IL255920B1 (en) 2024-01-01
CO2017013359A2 (es) 2018-03-28
EP3302065A4 (en) 2019-04-10
NZ737474A (en) 2022-11-25
JP2018520211A (ja) 2018-07-26
AU2021203074A1 (en) 2021-06-10
EP3302065A1 (en) 2018-04-11
EA201792602A1 (ru) 2018-06-29
ZA201707905B (en) 2018-11-28
BR112017025586A2 (pt) 2018-08-07
AU2016267672A1 (en) 2017-12-21
MX2017015145A (es) 2018-08-01
IL255920A (en) 2018-01-31
JP2021165289A (ja) 2021-10-14
KR20230145509A (ko) 2023-10-17
IL255920B2 (en) 2024-05-01
KR20180019613A (ko) 2018-02-26
CA2987064A1 (en) 2016-12-01
WO2016191724A1 (en) 2016-12-01

Similar Documents

Publication Publication Date Title
SG10201911206PA (en) Placental-derived stem cells to restore the regenerative engine, correct proteomic defects and extend lifespan
PL3346520T3 (pl) Ogniwo akumulatorowe i sposób jego wytwarzania
EP3313420C0 (en) METHODS AND COMPOSITIONS RELATING TO THE EXPANSION, ENRICHMENT AND PRESERVATION OF HEMATOPOIETIC STEM CELLS
HK1214143A1 (zh) 用於干細胞活動化、歸巢、擴增和分化的組合物及其使用方法
SG11201508027PA (en) Methods and compositions for mobilizing stem cells
EP2830126A4 (en) ELECTRODE FOR SECONDARY BATTERIES, METHOD FOR THE MANUFACTURE THEREOF, AND SECONDARY BATTERY AND WIRED SECONDARY BATTERY THEREWITH
EP2846381A4 (en) ELECTRODE FOR SECONDARY BATTERY, PRODUCTION THEREOF AND SECONDARY BATTERY AND SECONDARY BATTERY OF THE CABLE TYPE THEREWITH
HK1244017A1 (zh) 在間充質幹細胞中批量生產蛋白質的方法
EP3070163A4 (en) Method for preparing induced pluripotent stem cell, composition used in method, and uses thereof
EP3333947A4 (en) Metal porous body, fuel cell, and method for manufacturing metal porous body
WO2014168973A3 (en) Methods and compositions for rejuvenating skeletal muscle stem cells
HK1257561A1 (zh) 永生化幹細胞及其製作方法
EP3340333A4 (en) Curved battery cell having low structural deformation and method for manufacturing same
EP3349282A4 (en) Metal porous body, fuel cell, and method for manufacturing metal porous body
EP3017149A4 (en) WEARING SURFACE AND METHOD FOR MANUFACTURING THE SAME
IL254156A0 (en) Methods for producing neural stem cells and their use
EP3220464A4 (en) Cell structure, method for producing same, and fuel cell
EP3333948A4 (en) Metallic porous body, fuel cell, and method for manufacturing metallic porous body
GB201522003D0 (en) Regenerative fuel cells
HK1223826A1 (zh) 增強動員幹細胞的方案及組合物
GB201908394D0 (en) Stem cell conditioned media for clinic
GB201615150D0 (en) Double battery switched dual-purpose solar lamp
SG11201705754QA (en) Oil-extended rubber, rubber composition, and method for manufacturing the oil-extended rubber
EP3095864A4 (en) Novel method for labelling cancerization-causing cell in stem cells, and therapy method
EP2949239A4 (en) CELL UNIT FOR AIR MATTRESS AND AIR MATTRESS